APA (7th ed.) Citation

Xu, S., Luo, S., Zheng, X., & Weng, J. (2021, February 22). KLF2 is a therapeutic target for COVID-19 induced endothelial dysfunction bioRxiv. https://doi.org/10.1101/2021.02.20.432085

Chicago Style (17th ed.) Citation

Xu, Suowen, Sihui Luo, Xueying Zheng, and Jianping Weng. "KLF2 Is a Therapeutic Target for COVID-19 Induced Endothelial Dysfunction." BioRxiv 22 Feb. 2021. https://doi.org/10.1101/2021.02.20.432085.

MLA (9th ed.) Citation

Xu, Suowen, et al. "KLF2 Is a Therapeutic Target for COVID-19 Induced Endothelial Dysfunction." BioRxiv, 22 Feb. 2021, https://doi.org/10.1101/2021.02.20.432085.